Health Grants

National Institutes of Health · Amount varies

This NIH limited-competition program (P51) supports the activities of the National Primate Research Centers, which provide nonhuman primate resources to investigators nationally. Because it is a limited competition tied to the existing primate centers, eligibility is narrow; foreign institutions and foreign components are not eligible to apply, and applicants should consult the full announcement for eligibility details. No award amount is stated. This is effectively restricted to organizations operating designated primate research centers, not open to general applicants.

National Institutes of Health · Up to $350K

This NIH program (S15) helps eligible academic or research institutions buy modern equipment to modernize shared-use biomedical research facilities such as core labs and animal research facilities. Eligible applicants are institutions, including minority-serving institutions, HBCUs, and tribal colleges; foreign organizations and foreign components are not eligible. The award ceiling is about $350,000, and the program does not fund scientific research instruments themselves or building-level infrastructure. This is institution-focused support, not for individuals or general organizations.

National Institutes of Health · Up to $1.3M

This NIH/NCI program (U54) funds Specialized Centers within the Metastasis Research Network to pursue integrative, multidisciplinary basic research on cancer metastasis. Eligible applicants are research institutions, and notably foreign organizations, non-U.S. components of U.S. organizations, and foreign components are all eligible to apply here. The award ceiling is about $1.3M. This is a center-grant mechanism aimed at research institutions, not individuals or general organizations; see the NOFO for full eligibility details.

National Institutes of Health · Amount varies

The goal of the NIGMS Predoctoral Basic Biomedical Sciences Research Training Program is to develop a pool of well-trained scientists available to address the Nations biomedical research agenda. Specifically, this funding opportunity announcement provides support to eligible, domestic institutions to develop and implement effective, evidence-informed approaches to biomedical graduate training and mentoring that will keep pace with the rapid evolution of the biomedical research enterprise. NIGMS expects that the proposed research training programs will incorporate didactic, research, and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation.

National Institutes of Health · Amount varies

The specific purpose of this Notice of Funding Opportunity (NOFO) is to promote the development of a diverse, interdisciplinary workforce needed to conduct translational research on Alzheimer's disease and Alzheimer's-related dementias from target discovery through clinical development. This NOFO will support institutional training programs for predoctoral and postdoctoral level researchers with diverse educational backgrounds (i.e., basic biology, translational and clinical research, data science). The program invites eligible institutions to develop interdisciplinary training programs that will provide trainees with the knowledge and skills in data science, disease biology, behavioral research, and traditional and emerging drug discovery disciplines necessary to conduct rigorous and cutting-edge basic, translational, and clinical research for AD/ADRD.

National Institutes of Health · Amount varies

Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE). The program will fund P50 SPORE grants to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a highly related group of cancers. For the purpose of this FOA, a group of highly related cancers are those that are derived from the same organ system, such as gastrointestinal, neuroendocrine, head and neck, and other cancers. Other programmatically appropriate groups of cancers may include those centered around a common biological mechanism critical for promoting tumorigenesis and/or cancer progression in organ sites that belong to different organ systems. For example, a SPORE may focus on cancers caused by the same infectious agent or cancers promoted and sustained by dysregulation of a common signaling pathway. In addition, a SPORE may focus on cross-cutting themes such as pediatric cancers or cancer health disparities. The research supported through this program must be translational and must stem from research on human biology using cellular, molecular, structural, biochemical, and/or genetic experimental approaches. SPORE projects must have the goal of reaching a translational human endpoint within the project period of the grant.

National Institutes of Health · Amount varies

The National Heart, Lung, and Blood Institute (NHLBI) Program Project Grant (P01) supports research related to fundamental processes and diseases of the heart, blood and lymphatic vessels, lungs, and blood, including transfusion medicine, blood resources, and sleep disorders other programs including implementation science, health disparities, and translation research that address the mission of the Institute. This FOA requires a minimum of three interrelated research projects that investigate a complex biomedical theme or research question. The projects may be supported by core units, if justified, to facilitate economy of effort, space, and equipment. The NHLBI provides support for Program Project Grants (PPGs) in the belief that collaborative research efforts can accelerate the acquisition of knowledge more effectively than a simple aggregate of research projects that have no interaction or thematic integration. NHLBI is particularly interested in encouraging new scientific directions in PPGs. Use of the P01 activity code is viewed as an opportunity to attract scientists who have not traditionally been supported by the NHLBI. Further, the PPG environment presents an opportunity for emerging scientific leaders to gain insight into how to lead a successful scientific Program, and applicants will have the opportunity to include a project led by an Early Stage Investigator (ESI). All projects in the Program must be interrelated and have objectives that address a central theme within the scientific mandate of the NHLBI.

National Institutes of Health · Amount varies

The purpose of the Resource-Related Research Projects (R24) grant is to support investigator-initiated resources designed to provide materials and services to support and advance biomedical research on a national basis. An R24 resource grant mechanism is a non-hypothesis-driven activity to provide data, materials, tools, or services that are essential to making timely, high quality, and cost-efficient progress in a field. Hypothesis-driven research applications should not be submitted in response to this program announcement but to another mechanism that encourages this type of research. The resource should be available to any qualified investigator, and should be highly quality controlled, and not duplicate resources available commercially or through other sources. Resources should be designed to provide services to the broad alcohol research community and should not be limited by any specific regional focus.

National Institutes of Health · Amount varies

This NIH/ORIP resource award (R24) funds core facilities, resource centers, animal vivaria, or investigators to acquire equipment and study how environmental extrinsic factors affect animal research, aiming to improve rigor and reproducibility. The work must be broadly relevant to two or more NIH Institutes or Centers. Eligible applicants are institutions, including minority-serving institutions, HBCUs, and tribal colleges; foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components are otherwise allowed. No award amount is stated; eligibility centers on research institutions and shared-resource facilities.

National Institutes of Health · Amount varies

This NIH limited-competition program (U42) provides continuing support for specific pathogen-free macaque breeding colonies that supply animals for HIV/AIDS research, building on prior awards. Because it is a limited competition continuing previously funded colonies, eligibility is narrow; foreign organizations and foreign components of U.S. organizations are not eligible, and applicants should see the NOFO for details. No award amount is stated. This is effectively restricted to organizations operating the relevant macaque colonies, not open to general applicants.

National Institutes of Health · Up to $400K

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to encourage individuals who have not had substantial biomedical research experience, or who have the potential to significantly benefit from additional biomedical research experience to pursue further studies or careers in research. To accomplish the stated over-arching goal, this NOFO will support educational activities with a primary focus on: (1) Research Experiences, (2) Curriculum or Methods Development and (3) Outreach. The NCI’s mission is to conduct and support research, training, health information dissemination, and other programs concerning cancer. This funding opportunity seeks to facilitate educational activities that encourage students to become knowledgeable about cancer and available to focus on cancer later in their careers. To promote broad interest in pursuing a career in biomedical research via early intervention strategies, the NCI Youth Enjoy Science (YES) Program will support efforts to create and maintain an institutional program to engage grades 6-12 and/or undergraduate students in cutting edge cancer research experiences. The proposed institutional programs may also provide research experiences for the grade 6-12 teachers and undergraduate faculty members. The goals are to inspire interest in biomedical sciences, help envision research as a career path, and strengthen practical research and career skills. In alignment with these goals, institutions may develop unique programs that capitalize on their research strengths and are responsive to their target populations.

National Institutes of Health · Amount varies

This NIH BRAIN Initiative program (UH3) funds small clinical trials to advance next-generation devices for recording and modulating the human central nervous system. Eligible applicants are institutions, including minority-serving institutions, HBCUs, and tribal colleges; foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components are otherwise allowed. No award amount is stated. This is a clinical-research mechanism aimed at research institutions capable of conducting device trials.

National Institutes of Health · Amount varies

This NIH BRAIN Initiative program (UG3/UH3) is a milestone-driven cooperative agreement supporting translational development and small clinical studies of next-generation therapeutic and diagnostic devices for nervous and neuromuscular disorders. Eligible applicants are institutions, including minority-serving institutions, HBCUs, and tribal colleges; foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components are otherwise allowed. NIH program staff participate in project planning and monitoring. No award amount is stated; eligibility centers on research institutions able to develop and test devices.

National Institutes of Health · Amount varies

The purpose of the High Impact Specialized Innovation Programs (SIPs) is to support the development and demonstration of unique hub capabilities, research platforms and/or resources to address in a timely manner critical gap areas and/or roadblocks in clinical and translational science at awarded UM1 Clinical and Translational Science Awards (CTSA) Program Hubs (PAR-24-272). Successful programs supported through this funding opportunity are expected to lay a strong foundation for future adoption and/or dissemination of capabilities to additional CTSA Program Hubs.

National Institutes of Health · Up to $500K

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NIDCD R25 program is to support educational activities that help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral and clinical sciences.

National Institutes of Health · Up to $1.5M

This NIH (NIDDK) U24 cooperative agreement funds continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) Resource Center, supporting human cardiovascular tissue research. This is a single-source opportunity: only the University of Florida is eligible to apply, so no other organization qualifies. Foreign organizations and foreign components are not eligible, and clinical trials are not allowed under this mechanism. The stated maximum is about $1.5 million.

National Institutes of Health · Amount varies

This NIH U54 cooperative agreement funds establishment of a Center that trains researchers in product development for new substance use disorder (SUD) pharmacotherapeutics and advances promising concepts with technical and financial support. Unusually for NIH, foreign organizations and foreign components are eligible to apply under this opportunity. Clinical trials are not allowed under this mechanism. No specific award amount is stated; refer to the NOFO for full eligibility details.

National Institutes of Health · Up to $2.2M

This NIH (NIDDK) U24 cooperative agreement funds continuation of the Integrated Islet Distribution Program, which supplies human islets to diabetes researchers. It is a single-source opportunity: only the PI/PDs associated with the prior award to Beckman Research Institute/City of Hope are eligible, so no other organization qualifies. Foreign organizations and foreign components are not eligible, and clinical trials are not allowed. The stated maximum is about $2.2 million.

National Institutes of Health · Up to $500K

This NIH (NIDCD) U01 cooperative agreement funds high-risk clinical trials developing in vivo high-resolution imaging technologies for the living human inner ear; a clinical trial is required for this mechanism. Eligible applicants include a broad range of domestic and foreign organizations such as higher-education institutions (including minority-serving institutions), tribal governments, faith-based or community organizations, and U.S. territories. The stated maximum is about $500,000. A multidisciplinary team approach is encouraged; review the RFA for full eligibility details.

National Institutes of Health · Up to $500K

This NIH (NIDCD) R01 award funds development of in vivo high-resolution structural and functional imaging technologies for the living human inner ear. A wide range of domestic and foreign organizations may apply, including higher-education institutions (including minority-serving institutions), tribal governments, faith-based or community organizations, and U.S. territories. A clinical trial is optional. The stated maximum is about $500,000, and a multidisciplinary team approach is encouraged; review the RFA for full eligibility details.